The susceptibility of 12 strains of Mobiluncus curtisii and 10 strains of M. mulieris to 23 antimicrobial agents and 15 other compounds was determined. All strains were susceptible to chloramphenicol, clindamycin, rifampin, tobramycin, vancomycin, virginiamycin, and all beta-lactam antibiotics tested, including imipenem. One strain of M. mulieris was resistant to erythromycin and josamycin. All were resistant to colistin, cycloserine, nalidixic acid, and neomycin. Tetracycline had variable activity. All M. curtisii strains were resistant to metronidazole and its hydroxy metabolite. Of 10 M. mulieris strains, 5 were resistant to metronidazole and 2 were resistant to its hydroxy metabolite. All 12 M. curtisii and 1 of 10 M. mulieris strains were resistant to tinidazole. M. curtisii and M. mulieris produced two mutually exclusive clusters of MICs when tested against ampicillin, cefoxitin, cephalothin, moxalactam, alizarin red, Evans blue, and sodium fluoride. Gardnerella vaginalis was more susceptible to Nile blue A than was either M. curtisii or M. mulieris. Clindamycin and imipenem may be useful agents in the therapy of metronidazole-resistant bacterial vaginosis. Metronidazole, tinidazole, and Nile blue A may be of value in the development of a selective agar for Mobiluncus species.
Mobiluncus curtisii and M. mulieris (11) , curved, motile, anaerobic rods, are clearly associated with bacterial vaginosis (BV) (10, 12, 13) . Although their role in BV is not yet understood, reports of their presence in up to 50% of women with (10) and only 0 to 5% without (10, 12) BV have provoked a great deal of interest in these organisms. Several researchers have also reported that most or all strains of short curved rods (M. curtisii) (2, 4, 9, 10, 12) and some strains of long curved rods (M. mulieris) (2, 4, 10, 12) are resistant to metronidazole, the drug of choice for treating BV. One could speculate that the presence of metronidazoleresistant Mobiluncus spp. plays a significant role in recurrent BV, which occurs in 10 to 12% of women treated with metronidazole (1) . In that case, it will be important to know what other antimicrobial agents are active against them. Several reseachers have published susceptibility patterns, but recommended methods have rarely been used (5) . When methods have been modified, quality control has only rarely been included (2) .
The purpose of these studies was to use standardized methods to determine the susceptibility of 12 strains of M. curtisii and 10 strains of M. mulieris to a wide variety of antimicrobial agents and to use similar methods to determine their susceptibility to a selection of stains, dyes, and metabolic inhibitors as part of their phenotypic characterization. I also hoped that these data would guide me toward development of a selective medium for Mobiluncus species.
MATERIALS AND METHODS Source of strains. Susceptibilities were determined by using 22 well-characterized strains of Mobiluncus spp., including the type strains. The methods used for isolation, identification, and storage of these organisms have been published elsewhere (10, 11) . The activity of five antimicrot Address for reprint requests: University of Wisconsin Hospital and Clinics, C5/249 CSC, Madison, WI 53791-9452. bial agents against 10 of the M. curtisii and 3 of the M. mulieris strains was previously determined by using a different method (10) .
Activity of selected agents was also determined for six clinical isolates of Gardnerella vaginalis recovered from frozen stock. These isolates had been identified based on the presence of pleomorphic gram-variable rods which produced beta hemolysis on HBT agar (Regional Media Laboratories, Lenexa, Kans.) incubated in 5 to 10% carbon dioxide (7, 14) . One isolate was provided by L. Barth Reller, University of Colorado, Denver.
In vitro susceptibility testing. Susceptibilities were determined within five passages of recovery from frozen stock. MICs were determined either by microbroth dilution (antimicrobial agents) or agar dilution (other). Tests were performed in Wilkins-Chalgren broth (Anaerobe Broth, Experimental; Difco Laboratories, Detroit, Mich.) supplemented with 1% soluble starch (Difco), 2% rabbit serum (GIBCO Diagnostics, Madison, Wis.) and, for agar dilution tests ortly, 1.5% agar (Difco). Media were prepared on the bench top and reduced overnight in an anaerobic chamber (Coy Laboratory Products, Ann Arbor, Mich.) in an atmosphere of 10% hydrogen-10% carbon dioxide-80% nitrogen before inoculation.
The 23 antimicrobial agents tested were ampicillin (Sigma Chemical Co., St. Louis, Mo.), cefazolin ( Chalgren broth. This suspension was appropriately diluted to produce an inoculum of approximately 106 CFU/ml or spot. MICs were determined after 48 h of anaerobic incubation at 35°C. The MIC in broth was the minimum concentration at which there was no visible turbidity. The MIC on agar was the minimum concentration at which there was no more than a slight haze of growth or no more than two distinct colonies.
Quality control. Quality control of the antimicrobial agents was performed by using Bacteroidesfragilis ATCC 25285 for cefoxitin, chloramphenicol, clindamycin, imipenem, metronidazole, moxalactam, and tetracycline; Clostridium perfringens ATCC 13124 for penicillin G, Escherichia coli ATCC 25922 for cefazolin and tobramycin; and Enterococcus (Streptococcus) faecalis ATCC 29212 for ampicillin, cephalothin, erythromycin, and vancomycin.
RESULTS
Antimicrobial susceptibility. No quality control values were known for colistin, cycloserine, hydroxymetronidazole, josamycin, nalidixic acid, neomycin, rifampin, tinidazole, or virginiamycin. The tobramycin MIC was 32 times higher than expected, and the erythromycin MIC was four times greater than expected. The remaining 12 drugs were in control.
The results for the 22 Mobiluncus strains are in Table 1 .
All strains were susceptible to ampicillin, cefazolin, cefoxitin, cephalothin, chloramphenicol, clindamycin, imipenem, moxalactam, penicillin G, rifampin, tobramycin, vancomycin, and virginiamycin. All strains but one were susceptible to erythromycin and josamycin. All strains were resistant to colistin, cycloserine, nalidixic acid, and neomycin. All M. curtisii strains were resistant to metronidazole and hydroxymetronidazole. Whereas the MICs for 50 and 90% of the strains tested (MIC50 and MIC9o, respectively) were similar for metronidazole and its hydroxy metabolite against M. mulieris, the distribution of individual MICs was not. Whereas only 5 (50%) of 10 M. mulieris strains were susceptible to .8 ,ug of metronidazole per ml, 8 (80%) of 10 were susceptible to .8 ,ug of the hydroxy metabolite per ml (data not shown). All 12 M. curtisii and 1 of 10 M. mulieris strains were resistant to tinidazole. There was a bimodal distribution of tetracycline MICs; 10 of 12 M. curtisii and 2 of 10 M. mulieris strains were resistant. MICs could not be used to differentiate M. curtisii subsp. curtisii from M. curtisii subsp. holmesii (data not shown). However, M. curtisii and M. mulieris formed two distinct clusters of MICs when tested against ampicillin, cefoxitin, cephalothin, and moxalactam. In all of these cases, M. mulieris was more susceptible than M. curtisii. The only antimicrobial agent that was noticeably more active against M. curtisii than M. mulieris was colistin. One strain of G. vaginalis had a tinidazole MIC of 16 ,ug/ml, and that of the remaining five was 64 xg/ml. Stains, dyes, and metabolic inhibitors. No quality control values were available for these compounds. The MICs of these agents against Mobiluncus spp. and G. vaginalis are shown in Table 2 ; interpretations of susceptibility or resistance could not be made. MICs could not be used to differentiate M. curtisii subsp. curtisii from M. curtisii subsp. holmesii (data not shown). However, M. curtisii and M. mulieris formed two distinct clusters of MICs when tested against alizarin red, Evans blue, and sodium fluoride. M. mulieris was more susceptible to each of these agents. G. vaginalis was more susceptible to Nile blue A than was either M. curtisii or M. mulieris. 
DISCUSSION
Standard microtiter methods could not be used to determine the susceptibility of Mobiluncus spp. to antimicrobial agents because Wilkins-Chalgren broth does not adequately support their growth. To enhance growth, soluble starch (1%) and rabbit serum (2%) were added. Quality control organisms were used to show that these supplements did not alter the activity of the drugs tested. Of those agents whose values were known, only tobramycin and erythromycin were less active than expected. The anoxic capneic environment rather than the medium supplements may have decreased the activity of tobramycin and erythromycin (3) . In cases in which quality control values are lacking, it would not be prudent to use the data published herein to choose an agent for human use. The information may be valuable in choosing selective agents for in vitro use.
We are aware of six prior reports containing Mobiluncus susceptibility patterns (2, 4, 5, 9, 10, 12) . It should be noted that both strains of M. curtisii and one of the two strains of M. mulieris tested by Carlone et al. (2) were tested by Spiegel et al. (10) and that all four strains were tested in the present study. Only one of six studies that tested beta-lactam antibiotics found them inactive against Mobiluncus spp. (5) . With the exception of a single strain described in the present study, Hammann et al. (5) were the only researchers to report erythromycin resistance to Mobiluncus spp. (17 of 17 strains).
The activity of tetracycline against Mobiluncus spp. appears to be heterogeneous. Results may vary with the method used since the same two strains of M. mulieris tested by Carlone et al. (2) , which had MICS of 16 and 32 jig/ml, had MICs in the range <0.2 to 6.25 ,ug/ml in the present study.
Results of testing with the remaining agents was relatively consistent. We found higher MICs of chloramphenicol than had previously been reported. The resistance of these organisms to colistin and nalidixic acid has already been noted (4), and selective media containing these two antimicrobial agents have been used for primary isolation of Mobiluncus species.
Even though the quality control value was high, for reasons discussed above, tobramycin was very active against Mobiluncus spp. Aminoglycoside activity was reported in all four published works in which they were tested (2, 5, 9, 12) . As has been noted previously (9, 12) , it is highly unusual to detect aminoglycoside susceptibility in an anaerobic organism. The significance of this observation is unknown.
Whereas we found that MICs of ampicillin, cefoxitin, cephalothin, and moxalactam could apparently differentiate between M. curtisii and M. mulieris, Sprott et al. (12) found that erythromycin, metronidazole, and hydroxymetronidazole could serve that function.
All studies that differentiated M. curtisii (short curved rods) from M. mulieris (long curved rods) found that most or all strains of the former were resistant to metronidazole (2, 4, 9, 10, 12) . There is no such consensus regarding M. mulieris. The British and European literature reports them to be susceptible (4, 9, 12) , whereas we and others (S. L. Hillier and F. D. Schoenknecht, Abstr. Int. Conj. S. T. D. Meet. 1984, 86, p. 134) found some susceptible and some resistant strains. Skarin et al. (9) found that metronidazole was more active against Mobiluncus spp. than was tinidazole and that both drugs showed mutually exclusive clusters of MICs for the two species. In our hands, the range of MICs of the two drugs was almost the same when all members of the genus were considered, but M. mulieris had MICs from 2 to >512 ,ug/ml for metronidazole and 4 to 8 ,ug/ml for tinidazole. The relative resistance of Mobiluncus spp. to metronidazole and tinidazole may be advantageous in the development of a selective medium for their isolation from vaginal fluid.
The activity of the hydroxy metabolite of metronidazole was determined because of a previous report that it is more active against G. vaginalis than is the parent compound (8) . The greater activity of the metabolite against M. mulieris reported here may help explain why some patients with metronidazole-resistant strains respond to therapy with this agent. Sprott et al. (12) , however, did not find increased activity of hydroxymetronidazole against their strains.
Although Mobiluncus strains are susceptible to betalactam antibiotics, the presence of beta-lactamase-producing organisms in the vagina precludes their effective use in treating BV. Based on our data, oral or topical forms of clindamycin and imipenem may represent potential alternate modes of therapy when metronidazole fails. Both of these VOL. 31, 1987 antimicrobial agents have broad anaerobic coverage, and neither would be susceptible to the beta-lactamases of vaginal Bacteroides sp. Both, however, are active against vaginal lactobacilli and so may inhibit their regrowth during therapy. There is evidence that this contributes to treatment failures seen after treatment with ampicillin or amoxicillin (1) . Resistance to these alternate agents may also develop. Our single strain, which had a clindamycin MIC of 4 ,ug/ml, was isolated from a woman with BV that had been refractory to therapy with metronidazole and clindamycin. Hers was the strain resistant to erythromycin and josamycin, and it had the highest metronidazole MIC. Hammann et al. (5) reported clindamycin MICs as high as 8 ,ug/ml, which is considered resistant.
Caution should be exercised in interpreting these data because susceptibility was determind based on achievable levels in serum. The levels in vaginal fluid may be lower, or drugs which do achieve adequate levels may not be active in that environment (3) .
Many of the discrepancies between our data and those of others may be method dependent. Because there are no universally accepted methods for susceptibility testing, interpretation of results from laboratories in distant geographic locations can be difficult if not impossible. Modifications in media and incubation conditions which are made to support the growth of fastidious organisms may affect the results as seen in this study. Controls must be included to monitor the effects of these changes on the results.
The MICs of the stains, dyes, and sodium fluoride pointed out several compounds which might be useful in differentiating M. curtisii from M. mulieris, i.e., alizarin red, Evans blue, and sodium fluoride. Because sodium fluoride is a poison and cannot be placed in glass, its use will be limited. However, the use of alizarin red or Evans blue to differentiate the two species may be much faster than the currently recommended procedures (10) . This awaits further study.
Of all the antimicrobial agents (6) and other compounds tested, only Nile blue A has shown greater activity against G. vaginalis than Mobiluncus spp. The relative resistance of Mobiluncus spp. to metronidazole and tinidazole and the selective inhibition of G. vaginalis by low concentrations of Nile blue A will be used to pursue development of a selective agar for Mobiluncus species.
